X-131088709-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_144967.4(ARHGAP36):c.1568C>T(p.Pro523Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,210,157 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_144967.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP36 | NM_144967.4 | c.1568C>T | p.Pro523Leu | missense_variant | 12/12 | ENST00000276211.10 | |
ARHGAP36 | NM_001282607.2 | c.1532C>T | p.Pro511Leu | missense_variant | 12/12 | ||
ARHGAP36 | NM_001330651.1 | c.1160C>T | p.Pro387Leu | missense_variant | 11/11 | ||
ARHGAP36 | XM_011531280.2 | c.1160C>T | p.Pro387Leu | missense_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP36 | ENST00000276211.10 | c.1568C>T | p.Pro523Leu | missense_variant | 12/12 | 2 | NM_144967.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112315Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34479
GnomAD3 exomes AF: 0.00000549 AC: 1AN: 182175Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66679
GnomAD4 exome AF: 0.00000547 AC: 6AN: 1097842Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 1AN XY: 363212
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112315Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34479
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at